Detalhe da pesquisa
1.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Lancet Glob Health
; 11(11): e1743-e1752, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858585